Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT06093841Phase 2Active Not Recruiting
Relmacabtagene Autoleucel As Second-Line Therapy in Adult Patients with Aggressive B-cell NHL
Follicular Lymphoma Grade 3BHigh-grade B-cell LymphomaLymphoma, Large B-Cell, Diffuse+1 more
PrincipalinvestigatorStart date: 2023-11-03

Research Network

Collaboration Network

17 collaborators·16 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Weili Zhao, PhD

Ruijin Hospital

Moderately Similar
5 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseFollicular Lymphoma, Grade 3bHigh-grade B-cell Lymphoma+1 more

Worked with same sponsors:

Shanghai Ming Ju Biotechnology Co., Ltd.
Collaborated on 1 trial
Similarity Score44%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse
Similarity Score8%

Roberto Hernández Martín, MD

Hospital Virgen de la Concha

Related
2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse
Similarity Score8%

Elena Pérez Ceballos, MD

Hospital Morales Meseguer

Related
2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse
Similarity Score8%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse
Similarity Score8%

Sarit Assouline, MD

Jewish General Hospital

Related
5 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse
Similarity Score8%

Thomas E. Witzig, MD

Mayo Clinic

Related
12 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse
Similarity Score8%

Carlos Montalbán Sanz, MD

Hospital Universitario Ramon y Cajal

Related
2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse
Similarity Score8%

Hervé Tilly, MD

Lymphoma Study Association

Related
5 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse
Similarity Score8%

Mitchell S Cairo, MD

New York Medical College

Related
13 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06093841Phase 2PrincipalInvestigator

Relmacabtagene Autoleucel As Second-Line Therapy in Adult Patients with Aggressive B-cell NHL

Follicular Lymphoma Grade 3BHigh-grade B-cell LymphomaLymphoma, Large B-Cell, Diffuse+1 more
Active Not Recruiting

All 1 trials loaded